Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...

And they’re looking at different kinds of drugs that attack multiple myeloma in new ways. Here are some of the most promising areas of research. Targeted therapy: Chemotherapy kills fast-growing ...

Padma Bhushan awardee folk singer Sharda Sinha left for her heavenly abode on November 5, 2024, after her seven-year-long ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...

THRAP3, STMN1, and GNA13—are overrepresented in blood cancers like acute myeloid leukemia (AML) and could prove to be novel ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

Christopher R. Flowers, MD, MS, discusses what the current treatment landscape of follicular lymphoma looks like.

Genomic Determinants of Resistance to Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) Therapies in Patients with ...

Indapta Therapeutics, Inc., a privately held clinical stage biotechnology company developing next-generation differentiated cell therapies for the treatment of cancer and autoimmune diseases, today ...

Sanofi’s new multiple myeloma drug Sarclisa (isatuximab ... Sanofi used to be a major player in cancer when chemotherapy was standard of care, but has not kept pace with immunotherapy ...